Eli Lilly LLY.N said on Monday it sued three medical spas and online vendors for selling products claiming to contain ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...

New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...